In the analysis of MGMT and IDH-1, which are representative molecular biomarkers of brain tumors, EDB-FN expression between the MGMT methylated group and MGMT unmethylated group did not show any significant difference (both 1.5-fold). This evidence concerns the gene FN1 and brain neoplasm.